Dear Colleagues,

Prof. Fernando Schmitt (born in Santa Maria, Brazil, 1959) is a Professor of Pathology at the University of Porto and Head of Molecular Pathology at IPATIMUP. After passing his pathology training; completing a fellowship at the Karolinska Medical Hospital, Stockholm, Sweden; and rising to the rank of Professor of Pathology at the University of São Paulo (USP), Brazil, he relocated to Portugal, where he became one of the most influential cytopathologists and breast pathologists. Dr. Schmitt gained further international experience in Canada at the University Health Network, Toronto, and acted as the Director of the Department of Medicine at Laboratoire National de Santé, Luxembourg, before returning to Portugal, where he led the development of RISE (Clinical and Translational Research Network of the Medical Faculty) as its inaugural director.

Dr. Schmitt has authored over 500 papers in peer-review journals, 33 book chapters and edited six books. His research work is mainly focused on breast cancer, with an emphasis on molecular biomarkers, therapeutic targets and mechanisms of resistance. In recent years, his research work has been dedicated to the study of molecular markers on cytological material. His academic leadership is also reflected in his roles as the former President of the International Society of Breast Pathology and as the General Secretary and President-elect of the International Academy of Cytology (IAC); editorial work as the Editor in Chief of Pathobiology and Associate Editor of six major scientific journals; and membership of the WHO-IAC Classification of Tumours. Over his career, he has been bestowed with several awards, including Educator of the Year 2011 by the Papanicolaou Society of Cytology, GOLDBLATT AWARD 2013 by the IAC, Dario Cruz 2018 from the Portuguese League Against Cancer for his career as a breast cancer researcher, and the 2021 International Achievement Award from the American Society of Cytopathology.

Based on his most impressive career, and as his former PhD students, it is our unique privilege to act as guest editors for this Special Issue of Cancers in his honour. Our main goal is to highlight his outstanding achievements in breast cancer pathology and research, as well as his critical role in advancing the field. He remains an inspiration to all of us and we are very pleased to invite Fernando Schmitt’s collaborators and previous students to submit a publication to this Special Issue.

Dr. Joana Paredes
Dr. Jorge S. Reis-Filho
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• breast cancer
• pathology
• cytopathology breast cancer biology
• hereditary breast cancer
• biomarkers